Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?

Key PointsPatent cliff concerns continue to weigh down Bristol Myers Squibb's stock.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Sunday 13 September →